147 related articles for article (PubMed ID: 35878872)
1. Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model.
Javia A; Misra A; Thakkar H
Int J Pharm; 2022 Aug; 624():122045. PubMed ID: 35878872
[TBL] [Abstract][Full Text] [Related]
2. Design and pharmacodynamic evaluation of DPK-060 loaded Nanostructured lipid carrier embedded gel for dermal delivery: A novel approach in the treatment of atopic dermatitis.
Javia A; Misra A; Thakkar H
Colloids Surf B Biointerfaces; 2022 Sep; 217():112658. PubMed ID: 35810608
[TBL] [Abstract][Full Text] [Related]
3. Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.
Niemeyer-van der Kolk T; Buters TP; Krouwels L; Boltjes J; de Kam ML; van der Wall H; van Alewijk DCJG; van den Munckhof EHA; Becker MJ; Feiss G; Florencia EF; Prens EP; Moerland M; Burggraaf J; Rissmann R; van Doorn MBA
J Am Acad Dermatol; 2022 Apr; 86(4):854-862. PubMed ID: 33010325
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
Rubinchik E; Dugourd D; Algara T; Pasetka C; Friedland HD
Int J Antimicrob Agents; 2009 Nov; 34(5):457-61. PubMed ID: 19524411
[TBL] [Abstract][Full Text] [Related]
5. Optimisation and
Shiven A; Alam A; Dewangan HK; Shah K; Alam P; Kapoor DN
J Microencapsul; 2024 Aug; 41(5):345-359. PubMed ID: 38780157
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial.
Niemeyer-van der Kolk T; van der Wall H; Hogendoorn GK; Rijneveld R; Luijten S; van Alewijk DCJG; van den Munckhof EHA; de Kam ML; Feiss GL; Prens EP; Burggraaf J; Rissmann R; van Doorn MBA
Clin Transl Sci; 2020 Sep; 13(5):994-1003. PubMed ID: 32315497
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and
Walunj M; Doppalapudi S; Bulbake U; Khan W
J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
[TBL] [Abstract][Full Text] [Related]
8. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of a topical liposomal gel containing a combination of zedoary turmeric oil and tretinoin for psoriasis activity.
Chen J; Ma Y; Tao Y; Zhao X; Xiong Y; Chen Z; Tian Y
J Liposome Res; 2021 Jun; 31(2):130-144. PubMed ID: 32223352
[TBL] [Abstract][Full Text] [Related]
10. Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis.
Wang W; Shu GF; Lu KJ; Xu XL; Sun MC; Qi J; Huang QL; Tan WQ; Du YZ
J Nanobiotechnology; 2020 May; 18(1):80. PubMed ID: 32448273
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationship and biological evaluation of tetracationic gemini Dabco-surfactants for transdermal liposomal formulations.
Pashirova TN; Sapunova AS; Lukashenko SS; Burilova EA; Lubina AP; Shaihutdinova ZM; Gerasimova TP; Kovalenko VI; Voloshina AD; Souto EB; Zakharova LY
Int J Pharm; 2020 Feb; 575():118953. PubMed ID: 31843548
[TBL] [Abstract][Full Text] [Related]
13. Topical creams of piperine loaded lipid nanocarriers for management of atopic dermatitis: development, characterization, and
Kumar P; Sharma DK; Ashawat MS
J Liposome Res; 2022 Mar; 32(1):62-73. PubMed ID: 33944670
[TBL] [Abstract][Full Text] [Related]
14. Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice.
Kang MJ; Eum JY; Park SH; Kang MH; Park KH; Choi SE; Lee MW; Kang KH; Oh CH; Choi YW
Int J Pharm; 2010 Dec; 402(1-2):198-204. PubMed ID: 20888893
[TBL] [Abstract][Full Text] [Related]
15. Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in vitro and in vivo studies.
Madan S; Nehate C; Barman TK; Rathore AS; Koul V
Drug Dev Ind Pharm; 2019 Mar; 45(3):395-404. PubMed ID: 30442066
[TBL] [Abstract][Full Text] [Related]
16. Unique profile of antimicrobial peptide expression in polymorphic light eruption lesions compared to healthy skin, atopic dermatitis, and psoriasis.
Patra V; Mayer G; Gruber-Wackernagel A; Horn M; Lembo S; Wolf P
Photodermatol Photoimmunol Photomed; 2018 Mar; 34(2):137-144. PubMed ID: 29044786
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
18. Novel flexible vesicles based topical formulation of levocetirizine: in vivo evaluation using oxazolone-induced atopic dermatitis in murine model.
Goindi S; Kumar G; Kaur A
J Liposome Res; 2014 Sep; 24(3):249-57. PubMed ID: 24646413
[TBL] [Abstract][Full Text] [Related]
19. Design, optimization, and characterization of
Albratty M
J Biomater Sci Polym Ed; 2023 Dec; 34(17):2356-2375. PubMed ID: 37622439
[TBL] [Abstract][Full Text] [Related]
20. Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice.
Kang MJ; Eum JY; Jeong MS; Choi SE; Park SH; Cho HI; Cho CS; Seo SJ; Lee MW; Choi YW
Biol Pharm Bull; 2010; 33(1):100-6. PubMed ID: 20045944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
